Below are the most recent publications written about "Prognosis" by people in Profiles.
-
Sambanthamoorthy S, Ren Y, Galvez TK, King B, Liu SD, Kidd BA, Law DA, Baumgarth N. The Presence of CD11c+ B Cells with Potent Effector Memory Phenotype in Lung Adenocarcinoma Correlates with Overall Patient Survival. Cancer Immunol Res. 2026 May 04; 14(5):811-826.
-
Lam AC, Li Y, Brown MC, Deng Y, Hueniken K, Leighl NB, Shepherd FA, Murison K, Wang Z, Kothari J, Wenzlaff AS, Liu H, Kohno T, Pesatori AC, Harris C, Ma H, Dai J, Barnett MJ, Diver R, Leal LF, Fernandez-Tardon G, P?rez-R?os M, Davies MP, Holleczek B, Brennan P, Zaridze D, Holcatova I, Lissowska J, Swiatkowska B, Mates D, Savic M, Brenner H, Andrew AS, Taylor F, Field JK, Ruano-Ravina A, Shete SS, Tardon A, Wang Y, Marchand LL, Reis RM, Schabath MB, Neuhouser ML, Shen H, Landi MT, Shiraishi K, Zhang J, Schwartz AG, Tsao MS, Christiani DC, Yang P, Hung RJ, Xu W, Liu G. Evaluating eight smoking metrics for modelling survival in non-small cell lung cancer. Cancer Epidemiol. 2026 Jun; 102:103052.
-
Wallerson J, Rostampour S, Teng S, Kidane D. Dysregulated Peroxiredoxins in Bladder Cancer Are Associated With an Altered Tumour Immune Microenvironment. J Cell Mol Med. 2026 Mar; 30(5):e71064.
-
Andr?s A, Jim?nez S, Aladr?n Regidor MJ, Moreso F, Crespo M, Serra Caba?as N, G?mez G, L?pez V, Carmen D?az Corte MD, Fraile-G?mez P, Lorenzo I, Ruiz San Mill?n JC, Ca?as L, Rodr?guez Benot A, Calvo Romero N, Diekmann F, Mendiluce A, Fern?ndez Rivera C, Gallego R, Jim?nez C, Martin-Moreno PL, Fern?ndez Tagarro E, D?az C, Mart?n Urcuyo B, Gonz?lez Roncero FM. Clinical Outcomes and Quality of Life in Older De Novo Kidney Transplant Recipients Under Once-Daily Tacrolimus Formulations: The BITACORA Study. Clin Transplant. 2026 Mar; 40(3):e70501.
-
Gao YP, Fan YT, Cheng XQ, Huang PN, Liu HY, Bi XJ, Sun J, Zhu Y, Zhou W, Liu YN, Deng YB. Incremental Value of NT-proBNP Over HCM-AF Score in Risk Stratification for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. Clin Cardiol. 2026 Mar; 49(3):e70276.
-
Ofori-Minta K, Wang B, Mohl JE, Mandal A, Leung MY. Clinicogenomic Insights for Progression-Free Survival in Prostate Cancer. Int J Environ Res Public Health. 2026 Feb 18; 23(2).
-
Arif M, Basu A, Zuo BLG, Zuo MXG, O'Brien KJ, Pommerolle L, Caro-Rivera LM, De Jesus-Rojas W, Ramos-Benitez MJ, Behan M, Introne WJ, Frost G, Moaddel R, Gahl WA, Malicdan MCV, Gochuico BR, Cinar R. Choline and CCL22 Are Prognostic Blood Biomarkers for Hermansky-Pudlak Syndrome Pulmonary Fibrosis. Am J Respir Cell Mol Biol. 2026 Jan 01; 74(1):80-93.
-
Carbone M, Amos C, Attanoos RL, Boeri M, Bueno R, Bunn PA, Chirieac LR, Cooper B, Fennell D, Galateau-Salle F, Giannakou L, Goparaju CV, Hassan R, Hofman P, Kris MG, Mao W, Minaai M, Mitsudomi T, Molina TJ, Montuenga LM, Nabeshima K, Passaro A, Peters S, Rajan A, Richardson DB, Robbins H, Rolfo C, Rudin CM, Samet JM, Scherpereel A, Schrump DS, Sozzi G, Taioli E, Vison? SD, Yang H, Yoshikawa Y, Zhao A, Pass HI. Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact. J Thorac Oncol. 2026 01; 21(1):41-76.
-
Kuang H, Wang BN, Jia XY, Cui Z, Yu XJ, Jiang N, Borza DB, Zhao MH. Perlecan is a novel target of autoantibodies in anti-glomerular basement membrane disease. Nephrol Dial Transplant. 2025 Dec 23; 41(1):55-66.
-
Wannaphut C, Tanariyakul M, Yoshikawa GT, Hernandez BY, Villanueva NA, Acoba JD. Survival disparities in non-small cell lung cancer: Disaggregating Asians from NHPI and identifying variability among common Asian subgroups - The largest single-center study in Hawai'i. Cancer Epidemiol. 2025 Dec; 99:102904.